Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

By sjmartinez • January 9, 2025

Simpson EL, Hebert AA, Browning J, Serrao RT, Sofen H, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM. Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children. Dermatol Ther (Heidelb). 2025 Jan 7. doi: 10.1007/s13555-024-01318-6. Epub ahead of print. PMID: 39777610.

Tags: atopic dermatitis, Dermatology, Family impact, Olive View DoM, patient-reported outcomes, Publications, Quality of Life, Sleep improvement, Tapinarof cream 1% once daily, Topical aryl hydrocarbon receptor agonist

Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1

Morales A, Korsakova E, Mansooralavi N, Ravikumar A, Rivas G, Soliman P, Rodriguez L, McDaniel T, Lund A, Cooper B, Bhaduri A, Lowry WE. Probing[...]

Improvement of pruritus associated with erythrocytosis in transmasculine patients undergoing gender-affirming therapy with phlebotomy: a report of two patients

Galamgam J, Baroni E, Tsai S, Cheng CE. Improvement of pruritus associated with erythrocytosis in transmasculine patients undergoing gender-affirming therapy with phlebotomy: a report of[...]

Landscape of dermatology education in allopathic medical schools across the United States

Poppens M, McClain W, Collier E, Cheng K, Hogeling M. Landscape of dermatology education in allopathic medical schools across the United States. Dermatol Online J.[...]